Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bartenstein

Showing results (471-480 of 546) with videos related to

Pageof 55
Sort By:
Pharmaceuticals (Basel, Switzerland)|January 6, 2019
Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography ImagingRalf Schirrmacher, Justin J Bailey, Andrew V Mossine, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2022
Feasibility of [<sup>68</sup>Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinomaLena M Unterrainer, Simon Lindner, Lennert Eismann, et al.
Alzheimer'S Research & Therapy|August 3, 2019
Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer's disease tauMatthias Brendel, Maximilian Deussing, Tanja Blume, et al.
Cell Stem Cell|November 8, 2011
Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapyEnza Lonardo, Patrick C Hermann, Maria-Theresa Mueller, et al.
European Urology Focus|September 10, 2019
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Oligorecurrent Prostate Cancer Treated with Metastases-directed Radiotherapy: Role of Addition and Duration of Androgen DeprivationStephanie G C Kroeze, Christoph Henkenberens, Nina Sophie Schmidt-Hegemann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 29, 2018
Early and Longitudinal Microglial Activation but Not Amyloid Accumulation Predicts Cognitive Outcome in PS2APP MiceCarola Focke, Tanja Blume, Benedikt Zott, et al.
Journal of Neuroinflammation|July 15, 2020
Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learningFlorian Eckenweber, Jose Medina-Luque, Tanja Blume, et al.
Neuroimage|July 28, 2024
Towards multicenter β-amyloid PET imaging in mouse models: A triple scanner head-to-head comparisonJohannes Gnörich, Mara Koehler, Karin Wind-Mark, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2020
Asymmetry of Fibrillar Plaque Burden in Amyloid Mouse ModelsChristian Sacher, Tanja Blume, Leonie Beyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 18, 2020
Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [<sup>68</sup>Ga]PSMA-PET-guided metastasis-directed therapyMarco M E Vogel, Stephanie G C Kroeze, Christoph Henkenberens, et al.
Pageof 55

Showing results (471-480 of 546) with videos related to

Sort By:
Pageof 55
Pharmaceuticals (Basel, Switzerland)|January 6, 2019
Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography ImagingRalf Schirrmacher, Justin J Bailey, Andrew V Mossine, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2022
Feasibility of [<sup>68</sup>Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinomaLena M Unterrainer, Simon Lindner, Lennert Eismann, et al.
Alzheimer'S Research & Therapy|August 3, 2019
Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer's disease tauMatthias Brendel, Maximilian Deussing, Tanja Blume, et al.
Cell Stem Cell|November 8, 2011
Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapyEnza Lonardo, Patrick C Hermann, Maria-Theresa Mueller, et al.
European Urology Focus|September 10, 2019
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Oligorecurrent Prostate Cancer Treated with Metastases-directed Radiotherapy: Role of Addition and Duration of Androgen DeprivationStephanie G C Kroeze, Christoph Henkenberens, Nina Sophie Schmidt-Hegemann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 29, 2018
Early and Longitudinal Microglial Activation but Not Amyloid Accumulation Predicts Cognitive Outcome in PS2APP MiceCarola Focke, Tanja Blume, Benedikt Zott, et al.
Journal of Neuroinflammation|July 15, 2020
Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learningFlorian Eckenweber, Jose Medina-Luque, Tanja Blume, et al.
Neuroimage|July 28, 2024
Towards multicenter β-amyloid PET imaging in mouse models: A triple scanner head-to-head comparisonJohannes Gnörich, Mara Koehler, Karin Wind-Mark, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2020
Asymmetry of Fibrillar Plaque Burden in Amyloid Mouse ModelsChristian Sacher, Tanja Blume, Leonie Beyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 18, 2020
Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [<sup>68</sup>Ga]PSMA-PET-guided metastasis-directed therapyMarco M E Vogel, Stephanie G C Kroeze, Christoph Henkenberens, et al.
Pageof 55